Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Sino Biopharmaceutic (SBMFF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2020	12-2019	12-2018	12-2017	12-2016
Assets
Current Assets
Cash & Cash Equivalents	1,631,441	1,723,552	1,008,750	N/A	N/A
Marketable Securities	629,195	250,017	302,304	N/A	N/A
Receivables	422,250	392,457	441,823	N/A	N/A
Inventories	272,419	239,999	182,704	N/A	N/A
TOTAL	$3,302,880	$3,604,925	$2,801,111	$N/A	$N/A

Non-Current Assets
PPE Net	995,505	1,000,416	877,040	N/A	N/A
Investments And Advances	1,625,108	373,749	217,172	0	0
Intangibles	146,876	3,125,609	3,361,393	0	0
Other Non-Current Assets	770,424	331,202	265,074	0	0
TOTAL	$3,537,913	$4,830,976	$4,720,679	$N/A	$N/A

Total Assets	$6,840,792	$8,435,901	$7,521,790	$N/A	$N/A

Liabilities
Current Liabilities
Short Term Debt	225,004	96,479	439,032	N/A	N/A
Accounts payable and accrued liabilities	1,347,761	1,048,109	984,650	0	0
TOTAL	$1,585,719	$1,175,402	$1,460,929	$N/A	$N/A

Non-Current Liabilities
Long Term Debt	1,003,014	1,140,931	76,618	N/A	N/A
Other Non-Current Liabilities	663,033	-281,631	-254,830	0	0
TOTAL	$2,006,480	$1,431,323	$387,128	$N/A	$N/A

Total Liabilities	$3,592,198	$2,606,725	$1,848,056	$N/A	$N/A

Shareholders' Equity
Shares Outstanding, K	N/A	N/A	N/A	N/A	11,118,290
Common Shares	60,263	40,292	42,134	N/A	N/A
Retained earnings	1,516,875	2,252,054	2,184,975	N/A	N/A
Other shareholders' equity	1,282,518	1,773,889	1,600,922	0	0
TOTAL	$3,248,594	$5,829,177	$5,673,733	$N/A	$N/A

Total Liabilities And Equity	$6,840,792	$8,435,902	$7,521,789	$0	$0